Key Insights into the Intravenous Immunoglobulin Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theIntravenous Immunoglobulin Market?
The upswing in the elderly population is predicted to propel the progress of the intravenous immunoglobulin market. The elderly demographic constitutes individuals who are 65 years old or over. Due to the reduction in immunity and the scarcity of antibodies in aging individuals, they require immunoglobulins to provide necessary antibodies. This propels the demand for intravenous immunoglobulins and thus stimulates the advance of the intravenous immunoglobulin market. For example, the Population Reference Bureau, headquartered in Kenya, projected in January 2024 that the American population aged 65 and above will increase by 47%, leaping from 58 million in 2022 to 82 million by 2050. The proportion of this age group within the total population is also forecasted to rise from 17% to 23% in the same time frame. Consequently, the surging number of elderly individuals will fuel the expansion of the intravenous immunoglobulin market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp
#What Growth Opportunities Will Drive the Intravenous Immunoglobulin Market’s CAGR Through 2034?
The market size for intravenous immunoglobulin has experienced significant growth in recent years. It is predicted to increase from a value of $14.66 billion in 2024 to $15.72 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this historic growth include the treatment of primary immunodeficiency disorders, management of neurological conditions, an increase in the population of elderly individuals, advancements made in plasma fractionation techniques, and expanded indications in neurology, infectious disease treatment, and treatment of pediatric immunodeficiency.
The market size of intravenous immunoglobulin is predicted to undergo considerable expansion in the coming years, reaching $22.01 billion by 2029 with a compound annual growth rate (CAGR) of 8.8%. The projected increase during the forecast period can be credited to a heightened occurrence of autoimmune disorders, ongoing studies within the field of immunology, higher healthcare expenditures, increased instances of cancer, innovative developments in immunoglobulin products, and the application of personalized medicine methodologies. Leading trends during this forecast period are anticipated to be the treatment of primary immunodeficiency disorders (PIDD), fast-paced technological breakthroughs, strategic alliances and partnerships, improvements in manufacturing methods, neurology indications, uses in hematology, and the progress in immunotherapy.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8538
What Are the Latest Innovations Influencing theIntravenous Immunoglobulin Market?
A significant trend taking hold in the intravenous immunoglobulin marketplace is centred around product innovation. Leading companies are seeking to introduce new and innovative products such as fluid immune globulin formulae, which are aimed at addressing immunodeficiency illnesses, thereby maintaining their market stance. An example of this was seen in December 2023 when GC Pharma, a pharmaceutical firm from South Korea, released Alyglo which received the green light from the US Food and Drug Administration (FDA). Alyglo is a sterile, ready-for-use liquid solution that contains 10% immunoglobulin G (IgG), equating to 100 mg/mL of protein. At least 96% of this is human IgG that originates from pooled human plasma. It has been specially designed for the treatment of primary humoral immunodeficiency (PI) in adults who are 17 years or older, and this encompasses diseases like congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).
Who Are the Major Industry Players Accelerating Growth in theIntravenous Immunoglobulin Market?
Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Which Primary Segments of the Intravenous Immunoglobulin Market Are Driving Growth and Industry Transformations?
The intravenous immunoglobulin market covered in this report is segmented –
1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) By End-User: Hospitals, Clinics, Home Care
Subsegments:
1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG
2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM
3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA
4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE
5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8538&type=smpGlobal Intravenous Immunoglobulin Market, Global Intravenous Immunoglobulin Market Report, Global Intravenous Immunoglobulin Market Trends, Global Intravenous Immunoglobulin Market Size
Browse Through More Reports Similar to the Gobal Intravenous Immunoglobulin Maret 2025, By The Business Research Company:
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Immunofluorescence Assay Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
Immunoglobulins Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
